Hemagen Diagnostics, Inc. Successfully Completes Its Offer to Exchange 8% Senior Subordinated Secured Convertible Notes Due September 30, 2009

COLUMBIA, Md.--(BUSINESS WIRE)--William P. Hales, Chairman, President and CEO, of Hemagen Diagnostics, Inc., (OTCBB: HMGN) (the “Company”) today announced the successful completion of its Exchange Offer for $4,049,858.01 in principal amount of the outstanding 8% Senior Subordinated Secured Convertible Notes due September 30, 2009 (the “Old Notes”). Those tendering in the Exchange Offer received new 8% Senior Subordinated Secured Convertible Notes due September 30, 2014 (the “New Notes”) having the same principal amount as the Old Notes tendered for exchange. The Exchange Offer expired on Wednesday September 30, 2009, at Midnight and is effective as of that date. The Company has accepted all Old Notes tendered for exchange.